Back to search results
NCT06517576

Using Remote Monitoring to Address Health Disparities in Type 2 Diabetes

Enrolling by Invitation
NAAges 18+InterventionalPrevention
Lawndale Christian Health Center
~150 participants
Updated 2025-08-11 on ClinicalTrials.gov
What's tested:Blood glucose monitor with Digital Platform and Health CoachingContinuous glucose monitorUsual Care

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Glycated Hemoglobin
Measured over Baseline and at 4 Months
+6 more outcomes measured

Conditions

Diabetes Mellitus, Type 2

Explore related trials

Type 2 Diabetes Mellitus

Where it's being run

1 sites across 1 states
Illinois1

Study leadership

  • Andrew Wang · PRINCIPAL_INVESTIGATOR · Lawndale Christian Health Center

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18 years of age or older
Have an assigned primary care provider
Diagnosis of Type 2 diabetes
Medication use is insulin
HbA1c of 8.0% or higher

Exclusion

Diagnosis of chronic kidney disease at Stage 4 or higher
Diagnosis of pregnancy
Diagnosis of behavioral health conditions including serious mental illness or severe depression in the past 6 months.
All participants must have a smartphone that is able to access internet services.

What this trial measures

  • Glycated HemoglobinBaseline and at 4 Months

    HbA1c based on blood sugar attached to hemoglobin based on lab analysis of blood.

  • Blood Glucose4 Months

    Blood glucose measurements based blood glucose monitor (BGM) and continuous glucose monitor (CGMs).

  • Engagement with digital platform with a daily submission of blood glucose4 Months

    Daily blood glucose measurements from blood glucose monitor submitted to the digital platform

  • Implementation - Acceptability of Intervention Measure (AIM)Baseline and at 4 Months

    Self-reported perception among patients that this service is agreeable, palatable, or satisfactory with a likert scale of disagree to agree.

  • Implementation - Intervention Appropriateness Measure (IAM)Baseline and at 4 Months

    Self-reported perception among patients that this service is fit, relevant, and compatible with a likert scale of disagree to agree.

  • Implementation - Feasibility of Intervention Measure (FIM)Baseline and at 4 Months

    Self-reported perception among patients that this service is successfully used or carried out within a primary care setting with a likert scale of disagree to agree.

  • The Diabetes Self-Management Questionnaire (DSMQ) on eating, medication, glucose monitoring, physical activity, and healthcare useBaseline and at 4 Months

    Self-reported perception among patients of eating behavior, medication adherence, glucose monitoring, physical activity, and healthcare use with a likert scale of applies to me very much, applies to me a considerable degree, applies to some degree, and does not apply to me.